Skip to content

Clinical trials

Terminated Phase 3 Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 3 Status: Terminated Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20047
20056
20063
20078
20084
20093
20107
20116
20121
20132
20142
20154
20163
20172
20186
20194
20202
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated79

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Novartis Pharmaceuticals3
Amgen2
Ariad Pharmaceuticals2
Cell Genesys2
Egetis Therapeutics2
Grünenthal GmbH2
Hellenic Oncology Research Group2
Inovio Pharmaceuticals2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms79
Carcinoma9
Pain9
Carcinoma, Non-Small-Cell Lung8
Neoplasms by Site7
Neoplasm Metastasis6
Neoplasms by Histologic Type6
Head and Neck Neoplasms5
Anemia4
Liver Neoplasms4

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.